The one case with MTC harbored no BRAF mutation either in the thyroid cancer or pituitary adenoma specimen; the BRAF mutation occurred in 66.7% of thyroid cancer samples but was not detected in the pituitary adenoma samples from the acromegaly patients. This evidence concerns the gene BRAF and medullary thyroid gland carcinoma.